| dc.contributor.author | Kalincik, T. | |
| dc.contributor.author | Malpas, C. B. | |
| dc.contributor.author | Sharmin, S. | |
| dc.contributor.author | Roos, I. | |
| dc.contributor.author | Patti, F. | |
| dc.contributor.author | Butzkueven, H. | |
| dc.contributor.author | Sa, M. J. | |
| dc.date.accessioned | 2020-06-21T12:26:02Z | |
| dc.date.available | 2020-06-21T12:26:02Z | |
| dc.date.issued | 2019 | |
| dc.identifier.issn | 1352-4585 | |
| dc.identifier.issn | 1477-0970 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/10635 | |
| dc.description | 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS -- SEP 11-13, 2019 -- Stockholm, SWEDEN | en_US |
| dc.description | Ferraro, Diana/0000-0003-4818-3806; | en_US |
| dc.description | WOS: 000485303104029 | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | European Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltd | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Sage Publications Ltd | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Comparison of the effectiveness of rituximab versus alemtuzumab and natalizumab in active relapsing-remitting MS | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 25 | en_US |
| dc.identifier.startpage | 912 | en_US |
| dc.identifier.endpage | 914 | en_US |
| dc.relation.journal | Multiple Sclerosis Journal | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
